Norges Bank
AMRX icon

Norges Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Norges Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
+219,400
New +$3.01M ﹤0.01% 1416
2026
Q1 		– Sell
-889,500
Closed -$11.2M – 80
2025
Q4 		$11.2M Buy
+889,500
New +$10.2M ﹤0.01% 1284
2024
Q3 		– Sell
-86,200
Closed -$547K – 1842
2024
Q2 		$547K Buy
+86,200
New +$547K ﹤0.01% 1872
2023
Q2 		– Sell
-71,100
Closed -$98.8K – 2014
2023
Q1 		$98.8K Sell
71,100
-2,643,300
-97% -$5.26M ﹤0.01% 2084
2022
Q4 		$5.4M Buy
+2,714,400
New +$6.08M ﹤0.01% 1759
2022
Q2 		– Sell
-439,257
Closed -$1.83M – 2061
2022
Q1 		$1.83M Sell
439,257
-241,452
-35% -$1.07M ﹤0.01% 1990
2021
Q4 		$3.26M Sell
680,709
-80,544
-11% -$402K ﹤0.01% 1981
2021
Q3 		$4.07M Hold
761,253
– – ﹤0.01% 1957
2021
Q2 		$3.9M Sell
761,253
-46,653
-6% -$265K ﹤0.01% 1941
2021
Q1 		$5.44M Sell
807,906
-286,048
-26% -$1.59M ﹤0.01% 1896
2020
Q4 		$5M Hold
1,093,954
– – ﹤0.01% 1869
2020
Q3 		$4.25M Buy
1,093,954
+25,699
+2% +$110K ﹤0.01% 1893
2020
Q2 		$5.08M Sell
1,068,255
-59,249
-5% -$244K ﹤0.01% 1863
2020
Q1 		$3.92M Buy
1,127,504
+62,893
+6% +$266K ﹤0.01% 1860
2019
Q4 		$5.13M Sell
1,064,611
-371,481
-26% -$1.29M ﹤0.01% 1910
2019
Q3 		$4.17M Buy
1,436,092
+87,719
+7% +$306K ﹤0.01% 1930
2019
Q2 		$9.67M Hold
1,348,373
– – ﹤0.01% 1812
2019
Q1 		$19.1M Hold
1,348,373
– – 0.01% 1533
2018
Q4 		$18.2M Buy
1,348,373
+109,517
+9% +$1.97M 0.01% 1461
2018
Q3 		$27.5M Buy
1,238,856
+115,826
+10% +$2.44M 0.01% 1325
2018
Q2 		$18.4M Buy
+1,123,030
New +$19.7M 0.01% 1577

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Norges Bank's AMRX Position: Q2 2026 in Review

Norges Bank opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 219,400 shares worth $3.8M. The stake represents ﹤0.01% of the portfolio and ranks #1416 among its holdings. This is a return to the name: Norges Bank previously reported a position in AMRX as recently as Q4 2025.

Norges Bank first reported a position in AMRX in Q2 2018 and has held it in 21 quarters since. The position peaked at $27.5M in Q3 2018. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Norges Bank held 219,400 shares of Amneal Pharmaceuticals worth $3.8M as of Q2 2026.
  • Amneal Pharmaceuticals was a new Norges Bank position in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Norges Bank's portfolio in Q2 2026, its #1416 holding.
  • Norges Bank first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • Norges Bank's Amneal Pharmaceuticals position peaked at $27.5M in Q3 2018.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Norges Bank's 13F filing for Q2 2026, filed 12 Aug 2026.